HomeSABS • NASDAQ
add
SAB Biotherapeutics Inc
Previous close
$3.70
Day range
$3.69 - $3.95
Year range
$1.00 - $6.60
Market cap
193.66M USD
Avg Volume
613.64K
P/E ratio
54.70
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | -16.41M | 11.07% |
Net income | -16.86M | -47.97% |
Net profit margin | — | — |
Earnings per share | -0.41 | 58.04% |
EBITDA | -15.01M | -62.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 96.59M | 365.27% |
Total assets | 172.81M | 291.01% |
Total liabilities | 21.32M | 16.95% |
Total equity | 151.49M | — |
Shares outstanding | 50.95M | — |
Price to book | 1.16 | — |
Return on assets | -22.13% | — |
Return on capital | -23.99% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -16.86M | -47.97% |
Cash from operations | -16.78M | -76.00% |
Cash from investing | -1.71M | -118.29% |
Cash from financing | -41.68K | -119.21% |
Net change in cash | -18.92M | -6,825.84% |
Free cash flow | -8.77M | -26.90% |
About
Founded
2014
Headquarters
Website
Employees
86
